154 related articles for article (PubMed ID: 6187080)
1. New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.
Torisu M; Katano M; Kimura Y; Itoh H; Takesue M
Surgery; 1983 Mar; 93(3):357-64. PubMed ID: 6187080
[No Abstract] [Full Text] [Related]
2. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.
Katano M; Torisu M
Surgery; 1983 Mar; 93(3):365-73. PubMed ID: 6600854
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
Katano M
Fukuoka Igaku Zasshi; 1981 Oct; 72(10):543-55. PubMed ID: 7327499
[No Abstract] [Full Text] [Related]
4. Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432.
Hanaue H; Nomoto S; Kimura T; Kutsuna T; Takeuchi T; Yoshizaki S
Keio J Med; 1982 Dec; 31(4):159-68. PubMed ID: 6985379
[No Abstract] [Full Text] [Related]
5. Malignant ascites treated with streptococcal extract.
Lancet; 1983 Jun; 1(8336):1258. PubMed ID: 6134047
[No Abstract] [Full Text] [Related]
6. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
[TBL] [Abstract][Full Text] [Related]
7. [Management of malignant ascites with a streptococcal preparation, OK-432: induction of growth inhibition factor(s) against tumor cells].
Katano M; Yamamoto H; Hisatsugu T
Nihon Geka Gakkai Zasshi; 1986 Apr; 87(4):471. PubMed ID: 3713694
[No Abstract] [Full Text] [Related]
8. [Non-specific immunotherapy with OK-432, streptococcus pyogenes preparation, for inoperable cancer patients of the digestive tract].
Hanaue H; Nomoto S; Yoshizaki S; Kitano Y; Miyakawa S; Horie F; Kurosawa T; Nemoto A; Yasuda H; Takada T
Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1307-14. PubMed ID: 6512346
[No Abstract] [Full Text] [Related]
9. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
Hayashi Y; Torisu M
Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
[TBL] [Abstract][Full Text] [Related]
10. [Postoperative cell-mediated immunity in gastric cancer patients--with special reference to the effects of immunotherapy].
Sekizuka H; Noro K; Haruyama S; Kiribuchi Y; Hayashi F
Gan No Rinsho; 1985 Sep; 31(11):1381-6. PubMed ID: 3877822
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. II. Experimental study using human malignant ascites].
Umemoto T; Saji S; Oonishi A; Kunii Y; Goshima H; Tachibana S; Takao H; Tanemura H; Sakata K
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1512-7. PubMed ID: 3183459
[No Abstract] [Full Text] [Related]
12. Efficacy of streptococcal preparation OK-432 for gastric cancer patients--comparison between intradermal and intramuscular injection.
Hanaue H; Kurosawa T; Yoshizaki S; Shikata J
Jpn J Surg; 1984 May; 14(3):191-7. PubMed ID: 6611437
[TBL] [Abstract][Full Text] [Related]
13. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
[No Abstract] [Full Text] [Related]
14. [Administration of hemolytic streptococcus preparation OK-432 on recurrent gastric carcinoma].
Hanaue H; Kurosawa T; Kitano Y; Miyagawa S; Nemoto A; Yamato H; Asagoe T; Shikata J
Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1367-72. PubMed ID: 3501455
[No Abstract] [Full Text] [Related]
15. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
Katano M
Fukuoka Igaku Zasshi; 1981 Oct; 72(10):532-42. PubMed ID: 7327498
[No Abstract] [Full Text] [Related]
17. [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy].
Saito H; Kikkawa H; Bando H; Sakatoku M; Hirano M; Tatsuzawa T
Gan No Rinsho; 1988 Nov; 34(14):1965-8. PubMed ID: 3204664
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
Mori H; Itoh N; Tamaya T
Immunopharmacol Immunotoxicol; 1989; 11(1):33-53. PubMed ID: 2503555
[TBL] [Abstract][Full Text] [Related]
19. A patient with gastric carcinoma improved remarkably on intraperitoneal OK-432 therapy.
Yamagishi H; Ishibashi H; Kodama M; Tanaka T; Harada Y; Hashimoto I
Jpn J Surg; 1982; 12(6):434-41. PubMed ID: 7166915
[TBL] [Abstract][Full Text] [Related]
20. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]